Diamonds and Dogs


Sarepta Therapeutics (SRPT) jumping 25% thanks to better than expected earnings. The company beat estimates by 32 cents while revenue of $35.01 million blew past estimates of $22.52 million thanks to strong sales of their Duchenne muscular dystrophy (DMD) therapy, Exondys 51. Several upgrades for Sarepta with price targets of $64, $56, and $33 a share.

 Amazon is now hitting the home retailers. Home Depot (HD) is down 4% and Lowes (LOW) is down 5% on news Sears (SHLD) will offer Kenmore products on Once again when Amazon is mentioned in a new retail category, the stocks get hit. The sell offs are hopefully getting overdone.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.